Aridis Pharmaceuticals ARDS
$ 0.31
17.91%
Quarterly report 2023-Q3
added 11-06-2023
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Vu L. Truong |
Employees in the company |
25 |
Shares |
18.8 M |
Market Cap[1] |
$ 11.1 M |
EBITDA (LTM) |
$ -22.9 M |
P/E (LTM) |
- |
P/S (LTM) |
4.86 |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.